Sara K. Quinney, Pharm.D., Ph.D., is a Professor in the Department of Obstetrics and Gynecology and Division of Clinical Pharmacology, Department of Medicine, at Indiana University School of Medicine, where she serves as the Director of the Indiana Clinical and Translational Sciences Institute (CTSI) Pharmacometric Modeling and Simulation Program. She received her Pharm.D. and Ph.D. in pharmacy practice from Purdue University and completed clinical pharmacology and bioinformatics fellowships at Indiana University. Dr. Quinney utilizes in vitro, preclinical, clinical, and bioinformatics data to develop quantitative pharmacology models to improve understanding of drug disposition and response in special populations, particularly in maternal and pediatric populations. She leads the Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub Data and Model Knowledge Research Coordination Center (IU-OSU MPRINT DMKRCC), with a goal of enhancing maternal and pediatric pharmacotherapy through integrating data using innovative pharmacometric modeling approaches. Dr. Quinney also supports preclinical drug development efforts and serves as the clinical pharmacology and pharmacokinetic/ pharmacodynamic modeling expert for the IU Simon Comprehensive Cancer Center, Model Organism Development and Evaluation for Late-onset Alzheimer’s Disease (MODEL-AD) and the IU/Purdue Target Enablement to Advance Therapeutics for Alzheimer’s Disease (TREAT-AD) Preclinical Testing Cores. Dr. Quinney has served as a mentor to numerous students, residents, postdoctoral fellows, and junior faculty from a variety of disciplines.

Karel Allegaert is a paediatrician (1999), neonatologist (2000) and clinical pharmacologist (2003), and is currently appointed at KU Leuven, departments of Development and Regeneration, and Pharmaceutical and Pharmacological Sciences as full professor, with an additional appointment as senior consultant (10%) at Erasmus MC, Rotterdam (Hospital Pharmacy). His research has its focus perinatal and pediatric clinical pharmacology and its co-variates (maturational, non-maturational, pharmacogenetics, disease-related). In a truly international and interdisciplinary connection and collaboration, this resulted in a rather extended scientific output (650 PubMed papers, H index 55, https://www.webofscience.com/wos/author/record/C-3611-2016), and about 50 textbook chapters. The most relevant science categories are pediatrics, pharmacology and pharmacy, medicine research, microbiology and microbiology, toxicology, and lactation-related drug exposure. Links to retrieve the scientific output, as accessible in the public domain: https://www.researchgate.net/profile/Karel-Allegaert. The commitment to create societal impact is reflected in advisory tasks within the field of pharmacology and medicine, like membership of the commission on human medicines; council member Royal Academy of Medicine Belgium (since 2015); member trial board, KCE Belgium. He is also member of the HCP-WP and member of the expert screening panel on medical devices, of the European Medicines Agency, and highly involved in different pediatric formularies (kinderformularium, Australasian neonatal formulary, MADAM).

Catriona Waitt is a physician and NIHR Professor of Clinical Pharmacology and Global Heath at the University of Liverpool. Since 2015 she has been based at the Infectious Diseases Institute, Makerere University, Uganda where she established the Maternal and Infant Lactation pharmacoKinetics (MILK) research programme.